Fangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE
Fangzhou Inc. SHANGHAI, Nov. 07, 2025 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a…
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Research Highlights:
Results from the FigHTN Phase 2 clinical trial showed baxdrostat, a new medication that inhibits…